Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Drug Targets|November 15, 2014
Targeted Drug Delivery Systems for Lung MacrophagesAna Costa, Bruno Sarmento, Vítor Seabra
Expert Opinion on Drug Metabolism & Toxicology|November 12, 2013
An evaluation of the latest in vitro tools for drug metabolism studiesAna Costa, Bruno Sarmento, Vítor Seabra
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 13, 2017
Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophagesAna Costa, Bruno Sarmento, Vítor Seabra
Methods in Molecular Biology (Clifton, N.J.)|June 28, 2012
Chitosan-based nanoparticles as delivery systems of therapeutic proteinsPedro Fonte, José Carlos Andrade, Vítor Seabra, et al.
Pharmacogenomics|August 13, 2013
Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogeneticsAurea Lima, Rita Azevedo, Hugo Sousa, et al.
International Journal of Molecular Sciences|June 19, 2015
Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?Aurea Lima, Miguel Bernardes, Rita Azevedo, et al.
Plos One|October 4, 2014
Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patientsAurea Lima, Vítor Seabra, Miguel Bernardes, et al.
Acta Biomaterialia|April 21, 2019
Triple co-culture of human alveolar epithelium, endothelium and macrophages for studying the interaction of nanocarriers with the air-blood barrierAna Costa, Cristiane de Souza Carvalho-Wodarz, Vítor Seabra, et al.
International Journal of Pharmaceutics|October 18, 2015
Co-encapsulation of lyoprotectants improves the stability of protein-loaded PLGA nanoparticles upon lyophilizationPedro Fonte, Francisca Araújo, Vítor Seabra, et al.
Pageof 3